These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16918375)

  • 21. From the editor: Atherosclerosis in different flavors.
    Guyton JR
    J Clin Lipidol; 2019; 13(3):341-342. PubMed ID: 31229020
    [No Abstract]   [Full Text] [Related]  

  • 22. DNA methylation abnormalities in atherosclerosis.
    Tabaei S; Tabaee SS
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2031-2041. PubMed ID: 31116040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Advances in Immunonutrition and Atherosclerosis: A Review.
    Ruiz-León AM; Lapuente M; Estruch R; Casas R
    Front Immunol; 2019; 10():837. PubMed ID: 31068933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis.
    Doodnauth SA; Grinstein S; Maxson ME
    Philos Trans R Soc Lond B Biol Sci; 2019 Feb; 374(1765):20180147. PubMed ID: 30967001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular vesicles in atherosclerosis.
    Deng W; Tang T; Hou Y; Zeng Q; Wang Y; Fan W; Qu S
    Clin Chim Acta; 2019 Aug; 495():109-117. PubMed ID: 30959044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of oxidative stress on the development of atherosclerosis.
    Khosravi M; Poursaleh A; Ghasempour G; Farhad S; Najafi M
    Biol Chem; 2019 May; 400(6):711-732. PubMed ID: 30864421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanotechnological Strategies as Smart ways for Diagnosis and Treatment of the Atherosclerosis.
    Giménez VMM; Camargo AB; Kassuha D; Manucha W
    Curr Pharm Des; 2018; 24(39):4681-4684. PubMed ID: 30636583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis: cell biology and lipoproteins.
    Engelbertsen D; Rattik S; Björkbacka H
    Curr Opin Lipidol; 2019 Feb; 30(1):50-52. PubMed ID: 30585935
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.
    Xu S; Kamato D; Little PJ; Nakagawa S; Pelisek J; Jin ZG
    Pharmacol Ther; 2019 Apr; 196():15-43. PubMed ID: 30439455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-driven immunometabolic responses in atherosclerosis.
    Gisterå A; Ketelhuth DFJ
    Curr Opin Lipidol; 2018 Oct; 29(5):375-380. PubMed ID: 30156570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of innate immune cells: impact on atherosclerosis.
    Riksen NP; Stienstra R
    Curr Opin Lipidol; 2018 Oct; 29(5):359-367. PubMed ID: 30020200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis in the single-cell era.
    Winkels H; Ehinger E; Ghosheh Y; Wolf D; Ley K
    Curr Opin Lipidol; 2018 Oct; 29(5):389-396. PubMed ID: 30020199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell‑specific histone modifications in atherosclerosis (Review).
    Jiang W; Agrawal DK; Boosani CS
    Mol Med Rep; 2018 Aug; 18(2):1215-1224. PubMed ID: 29901135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poststatin era in atherosclerosis management: lessons from epidemiologic and genetic studies.
    Yvan-Charvet L; Cariou B
    Curr Opin Lipidol; 2018 Jun; 29(3):246-258. PubMed ID: 29553996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherosclerosis & ischaemic heart disease: Here to stay or gone tomorrow.
    Ndrepepa G
    Indian J Med Res; 2017 Sep; 146(3):293-297. PubMed ID: 29355133
    [No Abstract]   [Full Text] [Related]  

  • 36. Atherosclerosis: cell biology and lipoproteins - focus on anti-inflammatory therapies.
    Pfeiler S; Gerdes N
    Curr Opin Lipidol; 2018 Feb; 29(1):53-55. PubMed ID: 29298275
    [No Abstract]   [Full Text] [Related]  

  • 37. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target.
    Mitra R; O'Neil GL; Harding IC; Cheng MJ; Mensah SA; Ebong EE
    Curr Atheroscler Rep; 2017 Nov; 19(12):63. PubMed ID: 29127504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preface: Pathology and Pharmacology of Atherosclerosis.
    Foks AC; Bot I
    Eur J Pharmacol; 2017 Dec; 816():1-2. PubMed ID: 29108620
    [No Abstract]   [Full Text] [Related]  

  • 39. Atherosclerosis: Association between the gut microbiome and atherosclerosis.
    Barrington WT; Lusis AJ
    Nat Rev Cardiol; 2017 Dec; 14(12):699-700. PubMed ID: 29099096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerosis: Mitochondrial fission is crucial for efferocytosis.
    Fernanández-Ruiz I
    Nat Rev Cardiol; 2017 Dec; 14(12):696. PubMed ID: 29053156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.